Patents Assigned to The Prostate Cancer Research Centre
  • Cancer associated plexin B1 mutations
    Patent number: 7888007
    Abstract: The present inventors have identified cancer associated mutations in plexinB1, which is a transmembrane receptor that mediates semaphorin signaling. The frequency of plexinB1 mutations, in particular in prostate and breast cancer, indicates that plexinB1 may be useful in the screening and diagnosis of cancer and as a drug target in the development of anti-cancer therapeutics.
    Type: Grant
    Filed: November 28, 2003
    Date of Patent: February 15, 2011
    Assignee: The Prostate Cancer Research Centre
    Inventors: Magali Williamson, John Masters